Skip to main content
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.010
+0.050 (1.26%)
At close: Nov 13, 2026, 4:00 PM EST
3.994
-0.016 (-0.41%)
After-hours: Nov 13, 2026, 5:06 PM EST

Artiva Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-98.12-83.87-65.37-28.72-58.79-71.83
Depreciation & Amortization
2.782.62.432.271.160.25
Other Amortization
----4.08-
Loss (Gain) From Sale of Investments
-1.1-1.88-2.34-0.46--
Stock-Based Compensation
7.856.826.987.056.584.31
Other Operating Activities
-0-3.60.71-18.55
Change in Accounts Receivable
-0.02-1.03-0.51-0.06-0.47
Change in Accounts Payable
1.39-0.760.52-0.410.19-1.24
Change in Unearned Revenue
----26.53-2.4528.97
Change in Other Net Operating Assets
2.740.34-1.88-0.84-1.556.15
Operating Cash Flow
-84.48-76.75-55.03-47.43-50.83-15.3
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.12-2.59-0.64-3.26-6.3-1.72
Investment in Securities
-160.6466-119.82-22.72--
Investing Cash Flow
-162.7663.41-120.46-25.98-6.3-1.72

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.13-0.15---
Net Debt Issued (Repaid)
-0.08-0.13-0.15---
Issuance of Common Stock
300.430.14166.560.010.330.18
Repurchase of Common Stock
-0.3-0.23--0.01-0.01-
Other Financing Activities
-17.040.23-4.1824.39-1.59-2.03
Financing Cash Flow
283.010.01162.2324.39-1.26152.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
35.77-13.33-13.27-49.01-58.39135.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-86.6-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Growth
------
Free Cash Flow Margin
---22180.88%-151.34%-1158.55%-850.55%
Free Cash Flow Per Share
-2.47-3.25-4.95-63.14-74.51-24.83
Levered Free Cash Flow
-52.7-49.24-33.75-27.32-29.38-17.6
Unlevered Free Cash Flow
-52.7-49.24-33.75-27.32-29.38-17.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
---0.08--
Change in Working Capital
4.11-0.42-0.33-28.28-3.8733.41
SEC Filings: 10-K · 10-Q